pharma deals

Will surprise site inspections be the end of a long wait? Or the start of another tunnel into noncompliance?

GSK, the world’s largest vaccine maker by sales, has been under pressure to shore up its pipeline

Financial terms of the transaction are confidential

The complete integration and transition of the brands are expected to be completed by June 2022

The deal value was not disclosed

Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…

Under the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, and will also be eligible to receive…

This digital innovation represents impactful progress industry-wide, as it opens an opportunity for many life sciences…

The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…

Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6 per…